InsidersTradesSigma
Total declarations
Companies
▲ Purchases (19 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
19
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-30.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Flanders Scott N, Chief Executive Officer. Insider active across 2 companies, notably eHealth, Inc.. Cumulatively, 23 reports have been recorded. Split: 19 buys · 0 sell. Total volume traded: €1.9m. Activity tracked since 7 May 2021. The latest transaction was filed on 14 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations23 total
693,866 shares@ US$0.720623.9% of flowCommon StockSEC:0001578563-25-000179:0
Ideal exit: 9 Dec 2025 (T+270)
5,487 shares@ US$1.94930.5% of flowCommon StockSEC:0001578563-24-000495:0
Ideal exit: 6 Sept 2025 (T+270)
20,000 shares@ US$1.94781.9% of flowCommon StockSEC:0001578563-24-000469:0
Ideal exit: 24 Aug 2025 (T+270)
18,914 shares@ US$1.84491.7% of flowCommon StockSEC:0001578563-24-000468:0
Ideal exit: 19 Aug 2025 (T+270)
100,000 shares@ US$2.8513.4% of flowCommon StockSEC:0001578563-24-000413:0
Ideal exit: 9 Jun 2025 (T+270)
43,478 shares0Common StockSEC:0001578563-24-000409:0
15,832 shares@ US$1.89371.4% of flowCommon StockSEC:0001578563-24-000254:0
Ideal exit: 4 Mar 2025 (T+270)
9,400 shares@ US$1.79210.8% of flowCommon StockSEC:0001578563-24-000251:0
Ideal exit: 2 Mar 2025 (T+270)
7,237 shares@ US$1.74610.6% of flowCommon StockSEC:0001578563-24-000250:0
Ideal exit: 28 Feb 2025 (T+270)
3,066 shares@ US$1.69710.2% of flowCommon StockSEC:0001578563-24-000247:0
Ideal exit: 18 Feb 2025 (T+270)
1,251 shares@ US$1.64620.1% of flowCommon StockSEC:0001578563-24-000246:0
Ideal exit: 15 Feb 2025 (T+270)
23,000 shares@ US$1.5561.7% of flowCommon StockSEC:0001578563-24-000229:0
Ideal exit: 10 Feb 2025 (T+270)
25,000 shares@ US$1.50271.8% of flowCommon StockSEC:0001578563-24-000224:0
Ideal exit: 7 Feb 2025 (T+270)
300,000 shares@ US$2.0028.8% of flowCommon StockSEC:0001578563-23-000100:0
Ideal exit: 31 Aug 2024 (T+270)
15,432 shares0Common StockSEC:0001578563-23-000079:0
17,500 shares@ US$7.13455.9% of flowCommon StockSEC:0001578563-23-000068:0
Ideal exit: 11 May 2024 (T+270)
200 shares@ US$5.980.1% of flowCommon StockSEC:0001578563-23-000032:0
Ideal exit: 12 Feb 2024 (T+270)
14,737 shares@ US$5.633.9% of flowCommon StockSEC:0001578563-23-000031:0
Ideal exit: 6 Feb 2024 (T+270)
6,538 shares@ US$5.92921.9% of flowCommon StockSEC:0001578563-22-000040:0
Ideal exit: 10 Sept 2023 (T+270)
7,536 shares@ US$5.74852.1% of flowCommon StockSEC:0001578563-22-000039:0
Ideal exit: 5 Sept 2023 (T+270)
38,091 shares@ US$4.759.1% of flowCommon StockSEC:0001578563-22-000032:0
Ideal exit: 27 Aug 2023 (T+270)
500 shares@ US$58.610.017% mcap50.0% of flowCommon StockSEC:0001333493-21-000094:0
500 shares@ US$58.6150.0% of flowCommon StockSEC:0001333493-21-000094
23 of 23 declarations
About Flanders Scott N
Flanders Scott N serves as the Chief Executive Officer of eHealth, Inc. In this role, he is responsible for the strategic direction of the company and the management of its operations. His leadership is essential for achieving the company's objectives and for innovating in the digital health space.
